Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leif E Sander

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Cell|February 26, 2019
Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicansPetra Bacher, Thordis Hohnstein, Eva Beerbaum, et al.
Nature Cardiovascular Research|February 24, 2025
The cellular and molecular cardiac tissue responses in human inflammatory cardiomyopathies after SARS-CoV-2 infection and COVID-19 vaccinationHenrike Maatz, Eric L Lindberg, Eleonora Adami, et al.
Nature|December 1, 2025
Sustained HIV-1 remission after heterozygous CCR5Δ32 stem cell transplantationChristian Gaebler, Samad Kor, Kristina Allers, et al.
Cell|July 4, 2024
The life-saving benefit of dexamethasone in severe COVID-19 is linked to a reversal of monocyte dysregulationRainer Knoll, Elisa T Helbig, Kilian Dahm, et al.
Nature Immunology|May 15, 2023
CD4<sup>+</sup> T cell calibration of antigen-presenting cells optimizes antiviral CD8<sup>+</sup> T cell immunityElise Gressier, Jonas Schulte-Schrepping, Lev Petrov, et al.
Cell|October 15, 2020
A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster ModelJakob Kreye, S Momsen Reincke, Hans-Christian Kornau, et al.
Biorxiv : the Preprint Server for Biology|August 21, 2020
A SARS-CoV-2 neutralizing antibody protects from lung pathology in a COVID-19 hamster modelJakob Kreye, S Momsen Reincke, Hans-Christian Kornau, et al.
Immunity|September 30, 2021
Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19Benjamin Krämer, Rainer Knoll, Lorenzo Bonaguro, et al.
Cell|January 15, 2022
Complement activation induces excessive T cell cytotoxicity in severe COVID-19Philipp Georg, Rosario Astaburuaga-García, Lorenzo Bonaguro, et al.
Eclinicalmedicine|September 7, 2021
Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01January Weiner, Phillip Suwalski, Manuel Holtgrewe, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Cell|February 26, 2019
Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicansPetra Bacher, Thordis Hohnstein, Eva Beerbaum, et al.
Nature Cardiovascular Research|February 24, 2025
The cellular and molecular cardiac tissue responses in human inflammatory cardiomyopathies after SARS-CoV-2 infection and COVID-19 vaccinationHenrike Maatz, Eric L Lindberg, Eleonora Adami, et al.
Nature|December 1, 2025
Sustained HIV-1 remission after heterozygous CCR5Δ32 stem cell transplantationChristian Gaebler, Samad Kor, Kristina Allers, et al.
Cell|July 4, 2024
The life-saving benefit of dexamethasone in severe COVID-19 is linked to a reversal of monocyte dysregulationRainer Knoll, Elisa T Helbig, Kilian Dahm, et al.
Nature Immunology|May 15, 2023
CD4<sup>+</sup> T cell calibration of antigen-presenting cells optimizes antiviral CD8<sup>+</sup> T cell immunityElise Gressier, Jonas Schulte-Schrepping, Lev Petrov, et al.
Cell|October 15, 2020
A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster ModelJakob Kreye, S Momsen Reincke, Hans-Christian Kornau, et al.
Biorxiv : the Preprint Server for Biology|August 21, 2020
A SARS-CoV-2 neutralizing antibody protects from lung pathology in a COVID-19 hamster modelJakob Kreye, S Momsen Reincke, Hans-Christian Kornau, et al.
Immunity|September 30, 2021
Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19Benjamin Krämer, Rainer Knoll, Lorenzo Bonaguro, et al.
Cell|January 15, 2022
Complement activation induces excessive T cell cytotoxicity in severe COVID-19Philipp Georg, Rosario Astaburuaga-García, Lorenzo Bonaguro, et al.
Eclinicalmedicine|September 7, 2021
Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01January Weiner, Phillip Suwalski, Manuel Holtgrewe, et al.
Pageof 8